DPIIT recognised startup Government of India
Startup India
Baylor Pharmaceutical Private Limited - pharma in Navi Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹4.54 Cr
▲ 28% YoY
Net profit · FY 2025
₹34.09 Lakh
Net margin 7.5%
EBITDA · FY 2025
₹47.23 Lakh
EBITDA margin 10.4%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹35.2 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
7
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Baylor Pharmaceutical Private Limited
Data last updated:
Baylor Pharmaceutical Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85110MH2019PTC326121.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹35.2 Lakh. It is led by directors including Panni Prashob and Edadan Puthiyaveedu Suhesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No – 002 Chaudry Apt Sec – 29C Gothivali, Navi Mumbai, Maharashtra, India – 400701.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.54 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹34.09 Lakh (net margin 7.5%) and EBITDA of ₹47.23 Lakh (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 154% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website baylorpharma.com.
Company details
CIN U85110MH2019PTC326121
Registration Number 326121
Incorporation Date 30 May 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Panni Prashob Director Edadan Puthiyaveedu Suhesh Director Kandamkulngara Aneesh Director Recognitions & Rankings of Baylor Pharmaceutical
Contact details
Baylor Pharmaceutical Private Limited's registered office is in Navi Mumbai, Maharashtra.
- Social Media
- Registered AddressShop No – 002 Chaudry Apt Sec – 29C Gothivali, Navi Mumbai, Maharashtra, India – 400701
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Baylor Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Baylor Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Baylor Pharmaceutical Private Limited, buy the company report.
Financials of Baylor Pharmaceutical Private Limited
FY 2025 filings availableBaylor Pharmaceutical Private Limited reported revenue of ₹4.54 Cr (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹4.54 Cr ▲ 28%
Net profit · FY 2025
₹34.09 Lakh margin 7.5%
EBITDA · FY 2025
₹47.23 Lakh margin 10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 154%
EBITDA CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 224%
5 years · compounded
▲ 82%
Revenue has grown at a compounded annual rate (CAGR) of 154% over three years, including 28% growth in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Baylor Pharmaceutical Private Limited, buy the company report.
Board of directors of Baylor Pharmaceutical Private Limited
Baylor Pharmaceutical has 7 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Panni Prashob | Director | 02 Mar 2021 | 5 Years 8 Months | Current |
| Edadan Puthiyaveedu Suhesh Also directs: Baylor CV Pharmaceutical Private Limited | Director | 01 May 2021 | 5 Years 6 Months | Current |
| Kandamkulngara Aneesh | Director | 22 May 2021 | 5 Years 5 Months | Current |
| Anoop Murali | Director | 15 Dec 2023 | 2 Years 10 Months | Current |
| Kalathilparambath Sujil | Director | 15 Dec 2023 | 2 Years 10 Months | Current |
| Cheruliyil Mithun Das Also directs: Baylor Urotech Pharmaceutical LLP | Director | 15 Dec 2023 | 2 Years 10 Months | Current |
Showing 6 of 7 current directors. View all directors
Peer comparison
Baylor Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yug Enterprises Private Limited | ₹4.57 Cr (FY 2024) | 11.0% | New Delhi, Delhi, India | |||
| Adroit Lifescience Private Limited | ₹4.55 Cr (FY 2024) | -16.0% | Ahmedabad, Gujarat, India | |||
| Baylor Pharmaceutical Private Limitedthis company | ₹4.54 Cr (FY 2025) | ₹34.09 Lakh | 7.5% | 28.0% | Navi Mumbai, Maharashtra, India | |
| Healing Hands & Herbs Private Limited | ₹4.54 Cr (FY 2024) | 91.0% | Pune, Maharashtra, India | |||
| SGS Formulation Private Limited | ₹4.52 Cr (FY 2025) | -21.0% | Thiruvallur, Tamil Nadu, India |
To see the full peer comparison of Baylor Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Baylor Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Baylor Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Baylor Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Baylor Pharmaceutical Private Limited has 18 board changes on record since 2021: 7 appointments and 11 cessations. The latest: Sujesh Vallathana was appointed as Additional Director on 29 Aug 2025.
AGM
Baylor Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Sujesh Vallathana was appointed as Additional Director.
Filing
Baylor Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Anoop Murali ceased to be Additional Director.
Ceased
Cheruliyil Mithun Das ceased to be Additional Director.
Ceased
Kalathilparambath Sujil ceased to be Additional Director.
Appointed
Anoop Murali was appointed as Director.
Appointed
Cheruliyil Mithun Das was appointed as Director.
Appointed
Kalathilparambath Sujil was appointed as Director.
Ceased
Parachalil Muraleedharan Kishorkumar ceased to be Director.
Ceased
Pradeesh Puthan Purayil ceased to be Director.
Ceased
Naidulekha Aswani ceased to be Additional Director.
9 earlier events are in the company report.
Frequently asked questions
Baylor Pharmaceutical is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 May 2019 (7+ years old) and is registered under CIN U85110MH2019PTC326121.
Baylor Pharmaceutical has 7 current directors:
- Panni Prashob - Director
- Edadan Puthiyaveedu Suhesh - Director
- Kandamkulngara Aneesh - Director
- Anoop Murali - Director
- Kalathilparambath Sujil - Director
- Cheruliyil Mithun Das - Director
- Sujesh Vallathana - Additional Director
The latest financial statements of Baylor Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Baylor Pharmaceutical is U85110MH2019PTC326121. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baylor Pharmaceutical was incorporated on 30 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Baylor Pharmaceutical by revenue are Yug Enterprises Private Limited, Adroit Lifescience Private Limited, Healing Hands & Herbs Private Limited, SGS Formulation Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sujesh Vallathana was appointed as Additional Director on 29 Aug 2025. Anoop Murali ceased to be Additional Director on 29 Sep 2024. Cheruliyil Mithun Das ceased to be Additional Director on 29 Sep 2024. Baylor Pharmaceutical has 18 board changes on record in total.
Yes, Baylor Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Baylor Pharmaceutical can be reached through the website baylorpharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Baylor Pharmaceutical is at Shop No – 002 Chaudry Apt Sec – 29C Gothivali, Navi Mumbai, Maharashtra, India – 400701.
Baylor Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages